Cystic Fibrosis-related ProQR Names New Therapy Development Chief
cystic fibrosis, News
David M. Rodman is the new chief development strategy officer at ProQR Therapeutics, a leader in RNA therapies for cystic fibrosis (CF) and other diseases. Rodman, a medical doctor, will be ... Read more